{"schema_version":"secwatch.filing_event.v1","accession":"0000899923-23-000075","form_type":"8-K","ticker":"MYGN","cik":"0000899923","company_name":"MYRIAD GENETICS INC","filed_at":"2023-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.342530+00:00","generated_at":"2026-06-09T03:49:45.830154+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Myriad Genetics appoints Sam Raha as COO effective Dec 11, 2023","bullets":["Base salary $750k; annual target cash bonus 75% of base; sign-on bonus $500k with clawback provisions.","Initial RSU grant of $4M (two tranches of $2M each based on stock price at hiring announcement and start date).","Eligible for additional RSU grant of $2-3M in 2024, 50% time-vesting and 50% performance-vesting.","Raha previously President of Agilent Diagnostics & Genomics Group and VP Global Marketing at Illumina.","Raha will oversee lab operations, customer service, and product development innovations."],"urls":{"canonical":"https://secwatch.observer/filing/0000899923-23-000075","json":"https://secwatch.observer/filing/0000899923-23-000075.json","markdown":"https://secwatch.observer/filing/0000899923-23-000075.md","text":"https://secwatch.observer/filing/0000899923-23-000075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/899923/000089992323000075/0000899923-23-000075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899923/000089992323000075/mygn-20231101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T03:49:45.830154+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b24745e91","claim":"Samraat S. Raha was appointed as Chief Operating Officer at MYRIAD GENETICS INC.","evidence_excerpt":"On October 16, 2023, the Board of Directors (the \"Board\") of Myriad Genetics, Inc. (the \"Company\" or \"Myriad\") appointed Samraat S. Raha (\"Mr. Raha\") as the Company's Chief Operating Officer, effective as of December 11, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/899923/000089992323000075/0000899923-23-000075-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}